From the Guidelines
Januvia (Sitagliptin) is associated with several side effects, including pancreatitis, which has been reported but causality has not been established, and postmarketing and bullous pemphigoid, for which discontinuation is recommended if suspected 1.
Common Side Effects
- Pancreatitis: discontinue if suspected
- Postmarketing and bullous pemphigoid: discontinue if suspected
Important Considerations
- Dose adjustment is required based on kidney function for sitagliptin 1.
- The medication has a neutral effect on major adverse cardiovascular events (MACE), heart failure (HF), and chronic kidney disease (CKD) 1.
- It is essential to monitor patients for potential side effects and adjust treatment accordingly, particularly in those with pre-existing kidney impairment or at risk for pancreatitis 1.
From the Research
Side Effects of Januvia (Sitagliptin)
There are no research papers provided to assist in answering this question about the side effects of Januvia (Sitagliptin) as the studies mentioned are related to:
- Serotonin and Norepinephrine Reuptake Inhibitors 2
- Anti-seizure drugs for epilepsy 3, 4, 5
- General side effects and challenges associated with anti-epilepsy medication 6
These studies do not provide information about Januvia (Sitagliptin), which is used to treat type 2 diabetes. Some common points from the provided studies include: